What is NDC 27241-273?

27241-273 is the product NDC for Theophylline, Theophylline anhydrous 450 mg/1 tablet, extended release, listed with the FDA by Ajanta Pharma USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Theophylline?

40 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Theophylline NDC 27241-273 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-273Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0273Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-273-01	2724102730127241027301	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-273-01)Marketed from Jan 13, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Theophylline
Generic name (nonproprietary): theophylline
Active ingredients: Theophylline anhydrous — 450 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Ajanta Pharma USA Inc.NDC labeler code 27241
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218401
Marketing start: Jan 13, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Xanthines (Chemical structure)
Identifiers: Product ID 27241-273_fbec14fb-bd76-48e7-b61f-b19cd1a3ea2fSPL ID fbec14fb-bd76-48e7-b61f-b19cd1a3ea2fSPL set ID 7a422c32-bbdf-4297-84f4-9c438c904b0cRxCUI 314241, 317769UNII 0I55128JYKUPC 0327241273018, 0327241272011
Pharmacologic class: Methylxanthine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241027301 followed by a unit qualifier and the quantity

Package 27241-0273-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 27241-273

What is NDC 27241-273?: 27241-273 is the product NDC for Theophylline, Theophylline anhydrous 450 mg/1 tablet, extended release, listed with the FDA by Ajanta Pharma USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Theophylline.
What is the active ingredient?: Theophylline anhydrous.
Who is the labeler?: Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Theophylline?: 40 other product NDCs are listed under this name. See all Theophylline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Theophylline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Theophylline	Theophylline anhydrous 300 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-272	27241-0272-01
Theophylline	Theophylline anhydrous 450 mg/1	Tablet, Extended releaseOral	PD-Rx Pharmaceuticals, Inc.	72789-442	72789-0442-01
Theophylline	Theophylline anhydrous 300 mg/1	Tablet, Extended releaseOral	PD-Rx Pharmaceuticals, Inc.	72789-441	72789-0441-01
Theophylline	Theophylline anhydrous 300 mg/1	Tablet, Extended releaseOral	Strides Pharma Science Limited	64380-243	64380-0243-01
Theophylline	Theophylline anhydrous 450 mg/1	Tablet, Extended releaseOral	Strides Pharma Science Limited	64380-244	64380-0244-01
Theophylline	Theophylline anhydrous 300 mg/1	Tablet, Extended releaseOral	Harman Finochem Limited	82638-105	82638-0105-02
Theophylline	Theophylline anhydrous 450 mg/1	Tablet, Extended releaseOral	Harman Finochem Limited	82638-106	82638-0106-02
Theophylline	Theophylline anhydrous 300 mg/1	Tablet, Extended releaseOral	Viona Pharmaceuticals Inc	72578-173	72578-0173-01
Theophylline	Theophylline anhydrous 450 mg/1	Tablet, Extended releaseOral	Viona Pharmaceuticals Inc	72578-174	72578-0174-01
Theophylline	Theophylline anhydrous 300 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1782	70771-1782-01

All 41 Theophylline NDCs

Other NDCs under ANDA 218401

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218401
Product	Strength	Form · route	Labeler	Product NDC
Theophylline	Theophylline anhydrous 300 mg/1	Tablet, Extended releaseOral	Ajanta Pharma USA Inc.	27241-272